G SOL

Dosage form: spray
Ingredients: TITANIUM DIOXIDE 0.3g in 100mL, SILVER 0.01g in 100mL
Labeler: Egtech co., Ltd.
NDC code: 76767-020

Medically reviewed by Drugs.com. Last updated on May 9, 2025.

ACTIVE INGREDIENT

TITANIUM DIOXIDE 0.3%
SILVER 0.01%

INACTIVE INGREDIENT

Water, Sorbitan

PURPOSE

DISINFECTANT

WARNINGS

For external use only.
--------------------------------------------------------------------------------------------------------
Do not use
• in children less than 2 months of age
• on open skin wounds
--------------------------------------------------------------------------------------------------------
When using this product keep out of eyes, ears, and mouth. In case of contact with eyes, rinse eyes thoroughly with water.
--------------------------------------------------------------------------------------------------------
Stop use and ask a doctor if irritation or rash occurs. These may be signs of a serious condition.

KEEP OUT OF REACH OF CHILDREN

If swallowed, get medical help or contact a Poison Control Center right away.

Uses

Hand sanitizer to help reduce bacteria that potentially can cause disease.

Directions

Place enough product on hands to cover all surfaces. Rub hands together until dry.

Package Label - G Sol 30mL

Package Label - G Sol 60mL

Package Label - G Sol 450mL

G SOL
titanium dioxide, silver spray

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:76767-020
Route of Administration	TOPICAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
TITANIUM DIOXIDE (TITANIUM DIOXIDE)	TITANIUM DIOXIDE	0.3 g in 100 mL
SILVER (SILVER)	SILVER	0.01 g in 100 mL

Inactive Ingredients
Ingredient Name	Strength
Water
SORBITAN

Packaging
#	Item Code	Package Description
1	NDC:76767-020-01	30 mL in 1 BOTTLE, SPRAY
2	NDC:76767-020-02	60 mL in 1 BOTTLE, SPRAY
3	NDC:76767-020-03	450 mL in 1 BOTTLE, SPRAY

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		05/01/2020

Labeler - Egtech co., Ltd. (690074770)

Registrant - Egtech co., Ltd. (690074770)

Establishment
Name	Address	ID/FEI	Operations
GP&E Co., Ltd		689816478	manufacture(76767-020)

Revised: 05/2020

Document Id: f50499ed-e463-4332-b923-e338ceda7c7f

Set id: 0a8e1c7f-f7cc-43e7-956e-48524777012e

Version: 1

Effective Time: 20200519

Egtech co., Ltd.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

G SOL

Further information

See also:

Qulipta

Aimovig

Dupixent

Gemtesa

Ubrelvy

Nurtec ODT

Xeomin

Tazarotene topical

Topiramate

Dysport